Skip to main content
Future Journal of Pharmaceutical Sciences
Download PDF

Quisqualis indica Linn.: HRLCMS/MS profiling and anti-asthma activity of leaf extracts

Future Journal of Pharmaceutical Sciences volume 10, Article number: 13 (2024) Cite this article

Abstract

Background

Asthma is a chronic inflammatory disorder of the airways, involving various cells and cellular elements precisely eosinophils, mast cells, neutrophils, T lymphocytes, epithelial cells, and macrophages. Worldwide, about 300 million people are affected by asthma, and is expected that 100 million people may get affected, in 2025. Quisqualis indica is commonly planted as an ornamental plant in India; and has medicinal uses. Therefore, the petroleum ether (60–80 °C) LPE and methanolic extract LME of the Quisqualis indica leaves were analyzed for anti-asthmatic activity by mast cell degranulation and Milk induced eosinophilia and leukocytosis in mice.

Results

It was found that Quisqualis indica leaf extracts exhibited protection against the degranulation of mast cells and a reduction in the difference count of leucocytes and eosinophils. LPE and LME (400 mg/kg) have shown 33% and 63% of mast cell protection. LME has shown the most significant mast cell stabilizing action comparable with the standard drug. The extracts decreased the difference count of leucocytes and eosinophils. LME (400 mg/kg) has shown a difference in eosinophil count and a decrease in leukocyte count most comparable with the standard Dexamethasone. Methanolic extract analyzed for phytochemicals by High Resolution Liquid Chromatography Mass Spectroscopy /Mass Spectroscopy method showed the presence of various Phyto-compounds.

Conclusion

From the analysis of methanolic leaf extract of Quisualis indica revealed the presence of phytocompounds such as Apigenin7-glucoside, Gallic acid, Quercetin, Quercitrin, Kaempferol, etc. The significant decrease in eosinophil and leukocyte count in animals might be due to the higher content of Tannin and flavonoids. A reduction in leukocyte and eosinophil is regulated by type 1 hypersensitivity and adaptogenic factors hence Quisqualis indica is effectively helpful in allergy conditions like asthma.

Graphical abstract

Background

Asthma is a chronic inflammatory disorder of the airways, involving various cells and cellular elements, precisely eosinophils, mast cells, neutrophils, T lymphocytes, epithelial cells, and macrophages. Asthma is characterized by hindrance of airflow due to inflammation, bronchospasm, and increased airway secretions. [1] About 300 million people worldwide suffer from asthma, and by 2025, it's predicted that 100 million more will likely develop the condition. The prevalence, severity, and mortality of asthma are greatly affected by geographical variation. Asthma incidence is greater in high revenue countries, and maximum death caused by asthma happens in low middle revenue countries [2].

The multifaceted condition known as asthma is brought on by complex relationships between the environment and heredity. The pathophysiology of this condition includes intermittent airflow restriction, bronchial hyperresponsiveness (BHR), inflammation of the airways and bronchial remodeling. Depending on the severity of the condition, bronchodilators and anti-inflammatory medications can be used to treat asthma. Then, additional treatments are still required to better control asthma, and herbal remedies may be a viable substitute for current synthetic medications [3]. Additionally, plant polyphenols are potent components of natural foods and herbal medicine that have anti-inflammatory, antioxidant, and anti-allergic properties. Previous studies have demonstrated the anti-inflammatory effects of resveratrol, genistin, luteolin, and quercetin, as well as their multiple targets, multiple links, and comprehensive coordination [4].

The plant Quisqualis indica Linn. (Combretaceae) is an evergreen plant planted in homes and gardens of countries like India, China, Australia, the Amazonian region in Peru, and Pakistan. It is a large sub-woody climber shrub with 3–8 m long branches. Leaves are simple, oppositely having an oblong-elliptic to elliptic shape. It bears the inflorescence with white to pink-colored flowers. Flowers appear in constant succession in sagging clusters with a sweet scent [5, 6].

The leaves of Quisqualis indica were used to isolate four crystalline components, which were later identified as nicotinic acid and methylbetaine (trigonelline), L -proline, L -asparagines and potassium quisqualate [7]. Triterpenoids, flavonoids and tannins were isolated from the petroleum ether and methanolic extract of leaf and flower, respectively [8]. Ethno-pharmacologically, the flowers, fruit, seeds, leaves, stem and roots of the plant are used. Leaves are used to relieve pain caused by fever. Leaves decoction is given for flatulent distension and pain in the abdomen. Leaf juice is used to heal boils and ulcers [9]. Fruits and seeds are used in folk medicine as anthelmintic, anti-emetic, and anti-diarrhoea [10].

Different parts of plant have been studied for various pharmacological actions such as anti-microbial [11], anthelmintic [12], anti-pyretic [13], anti-inflammatory [14], anti-oxidants [15], insecticidal [16], immunomodulatory [17], anti-diarrheal [18], etc. due to the existence of various phytoconstituents. The stem bark and flowers were evaluated for the total tannin content and anti-oxidant activity [19]. Roots are used to treat rheumatism, cough and hiccup by Philippines [3, 20, 21]. As the whole plant is used as cough cure [10]; in the current work, we have looked into the phytoconstituents and anti-asthma activity of the Quisqualis indica leaves. The leaf petroleum ether extract (LPE) and leaf methanolic extract (LME) of Quisqualis indica were screened for phytochemicals by High Resolution Liquid Chromatography Mass Spectroscopy /Mass Spectroscopy (HRLCMS/MS) and anti-asthma activity. In the case of Quisqualis indica extract, which is high in flavonoids and phenolic compounds, reduces inflammation [14] and act as an immunomodulatory. [17]

Methods

Collection and preparation of plant material

The fresh leaves of Quisqualis indica Linn. plant were collected from the residential region in the Indian state of Maharashtra near Nashik. The plant was verified by the India Botanical Survey, which included Pune and Maharashtra [22, 23]. The allotted authentication No. was BSI/WRC/IDEN.CER/2016/403 (A). The pulverized and sieved dried leaf powder was processed. The petroleum ether (60–80 °C) and methanol solvents were used to extract the phytochemicals such as steroids, flavonoids, tannins; alkaloids, etc. The petroleum ether (60–80 °C) and methanol solvents were used in a continuous hot percolation process (Soxhlet extraction) to extract the coarse powder successively for 48 h. A rotating vacuum evaporator (Evator) was used to concentrate the liquid extracts to produce a semisolid extract [24, 25].

Animals

The healthy adult Wistar albino mice (20–25 g) of either sex were housed in polypropylene cages, under 12 h light: 12 h dark cycle and temperature 22 ± 2 °C and humidity 55 ± 5% maintained in the animal house. The animals had free access to food and water. All the animals were deprived of food but not of water 4 h before the experiment [26]. The Institutional Animal Ethical Committee of the institute (Registration No. 121/1999/CPCSEA) has approved all the protocols of the study (Registration No. IAEC/Jan 2020/09).

Acute oral toxicity study

The acute oral toxicity study OECD guideline (2001) [26, 27] was followed to carry out acute toxicity study for the extracts of Quisqualis indica plant.

Mast cell degranulation

There were six groups of mice in total, with six mice in each group. A three-day treatment for drugs program has been followed properly. Group I Control groupwas given the treatment with 1% tween 80 solutions (5 ml/kg, i.p.); Group II received standard drug Sodium chromoglycate (50 mg/kg, i.p) and all test groups Group III to Group VI received LPE and LME at doses of 200 and 400 mg/kg. On the fourth day, 10 mL/kg of 0.9% saline solution was gently massaged into the peritoneal cavity of each mouse before being injected. Five minutes later, the peritoneal fluid was collected. The peritoneal fluid was then put into a test tube containing 7–10 mL of RPMI-1640 buffer medium (pH 7.2–7.3), which is made up of L-glutamine and 25 mM HEPES buffer but not sodium bicarbonate. At 400–500 rpm, this solution was then centrifuged. Centrifugation was used to rinse the mast cells pellets twice with RPMI-1640 buffer media, and the supernatant was rejected. Egg albumin was used to challenge the cell suspension produced from both the treated and control groups of mice, which was then incubated at 37 °C for 10 min.After being stained with 1% toluidine blue, the cells were examined under a microscope. Mast cells that had degranulated were seen as rupture cells rather than whole. In total of 100 cells from various visual regions were counted, and the percentage of protection against degranulation was calculated [28, 29].

$$\% Protection mast cell= [1-(T / C)] x 100$$

where, T- No. of degranulated cells of test

C-No. of degranulated cells of control

Milk induced eosinophilia and leukocytosis

There were six groups of mice, six animals in every group. Blood samples (0.5 ml) were collected from the retro-orbital plexus. Group I Control group received vehicle, tween 80 (1%) solution (5 ml/kg, i.p.); Group II received Standard drug Dexamethasone (50 mg/kg, i.p) and test groups Group III to Group VI received LPE and LME at doses 200 and 400 mg/kg. Amul’s Fresh milk was procured from the local market. All animals were treated with an injection of freshly cooked and chilled milk (4 mL/kg, s.c.) for 30 min following treatments. Total leukocyte and eosinophil count were carried out in each group before drug administration and 24 h after the milk injection. Difference in total leucocytes count before and after 24 h of drug administration was calculated [30, 31].

Statistical analysis

All the results of various studies were expressed as mean ± Standard Error of Mean. Data was analyzed using a one-way ANOVA, which was followed by Dunnet’s Multiple Comparison Test. P < 0.05 was considered statistically significant. The graphs were calculated with the GraphPad Prism 5.

HRLCMS/MS profiling

The phytochemicals of the bioactive extract (LME) were analysed by HRLCMS/MS method. High-resolution liquid chromatography combined with the Q-Exactive Plus Mass Spectrometer TOF/Q-TOF mass spectrometer with ion source dual AJS electrospray ionization (ESI) was used [32]. The plant extract (50 mg) was dissolved in 1 mL of water: acetonitrile (1:1) solvent mixture, ultrasonically processed for 10 min, and then centrifuged at 10,000 rpm for 10 min. The ZORBX Eclipse Plus C18, narrow bore 2.1 150 mm with 5 microns, was used for the LC/ESI-QTOF-MS/MS analysis. An amount of 5µL was delivered in both positive as well as negative mode. The Mass Spectra scan range was in 120 to 1200, with 1.00 scans rate spectra/second and 1.00 as MS/MS scan rate spectra/second. The gradient elution procedure was done by changing the proportion of water and acetonitrile from 95 to 5% within 30 min, with flow rate of 0.3 mL/min as a constant flow rate. Then, this section was linked to the TOF/Q-TOF Mass Spectrometer for MS/MS fragmentation spectra. Phytochemicals were recognized by comparing their m/z and MS/MS transitions with those documented in reference databases. Further, the molecular formula, retention time, and adduct formula were detected.

Results

Acute oral toxicity study

Oral administration of plant extracts shows no significant body weight variation, neither any sign of toxicity nor mortality of mice at the dose of 2000 mg/kg, body weight.

Mast cell degranulation

In the pathogenesis of allergic asthma, mast cells also play a crucial role. Inhaled antigens enter the lower respiratory tract and produce localised mast cell degranulation and inflammation that trigger an inflammatory response in the airways. These circumstances cause edema, fluid build up, and increased vascular permeability, which can block the airways. Asthma-related airway obstruction can result from bronchial constriction, which can happen as a result of smooth muscle contraction [33]. Novel medications or treatments that help lessen asthma symptoms by lowering the production of these inflammatory mediators can be found by researching the inhibition of mast cell degranulation. In the present study, the effect of LPE and LME at doses of 200 and 400 mg/kg, body weight was examined on mast cell degranulation. The control group showed (83.4 ± 0.34) degranulation of mast cells while groups pre-treated with extracts and disodium chromoglycate significantly protect degranulation of mast cells. [34, 35] LME at dose (400 mg/kg) showed (31.6 ± 3.67) and disodium chromoglycate (26.86 ± 2.34) protection against degranulation as shown in Figs. 1 and 2.

Fig. 1
figure 1

Effect of Quisqualis indica leaf extracts on egg albumin induced degranulation of mast cell

Full size image
Fig. 2
figure 2

Mast cell granulated and degranulated

Full size image

Values are in Mean ± SEM, *P < 0.05 when compared against control, n = 6. One Way ANOVA was used to analyze all the data, and then Dunnett's test was performed. The graph was calculated by using PRISM 5 Software.

Milk induced eosinophilia and leukocytosis

Airway hyperresponsiveness (AHR), reversible airflow restriction, and airway inflammation are all symptoms of bronchial asthma, a chronic condition. Eosinophilic asthma and non-eosinophilic asthma are two types of asthma's pathophysiological mechanisms. According to recent studies, eosinophils are crucial to the emergence of asthma exacerbations. Immune-modulatory reactions brought on by a high blood eosinophil count include airway inflammation, hyperresponsiveness, epithelial lining damage, and increased mucus secretion, Eosinophilic inflammation affects nearly fifty percent of asthma sufferers. Studies have proven that eosinophilia has been associated with higher disease severity, exacerbation frequency, and symptom burden, as well as decreased lung functions [36]. Therefore, eosinophilic inflammation must be suppressed and eosinophilic and non-eosinophilic asthma must be distinguished in order to treat or avoid asthma aggravation [37]. The maximum increase in difference of eosinophil (578.00 ± 11.10) and leucocytes (11,266.16 ± 149.63) counts was found in the control group which has been treated with milk (4 mL/kg, s.c.) before 24 h Quisqualis indica extracts at doses of 200 and 400 mg/kg significantly inhibited milk-induced eosinophilia and leucocytosis in a manner dependent on dose. Like Dexamethasone [38], the LME (400 mg/kg) exhibits substantial inhibition as shown Figs. 3 and 4.

Fig. 3
figure 3

Effect of Quisqualis indica leaf extracts on Milk induced eosinophilia

Full size image
Fig. 4
figure 4

Effect of Quisqualis indica leaf extracts on milk induced leukocytosis

Full size image

Values are in Mean ± SEM, ***P < 0.05 when compared against control, n = 6. One Way ANOVA was used to analyze all the data, and then Dunnett's test was performed.The graph was calculated by using PRISM 5 Software.

Values are in Mean ± SEM, ***P < 0.05 when compared against control, n = 6. One Way ANOVA was used to analyze all the data, and then Dunnett's test was performed. The graph was calculated by using PRISM 5 Software.

LCMS/MS study of the bioactive extract

The LC–MS chromatogram of the methanolic extract of Quisqualis indica is shown in Figs. 5 and 6, and the important identified compounds are given in Tables 1 And 2.

Fig. 5
figure 5

Chromatogram of LME of Quisqualis indica positive ESI

Full size image
Fig. 6
figure 6

Chromatogram of LME of Quisqualis indica negative ESI

Full size image
Table 1 Important compounds identified in LME extract of Quisqualis indica by HRLCMS/MS positive ESI
Full size table
Table 2 Important compounds identified in LME extract of Quisqualis indica by HRLCMS/MS negative ESI
Full size table

Discussion

A persistent inflammatory illness of the airways is allergic asthma. Leukocyte infiltration into the lung and airway is the primary characteristic of asthma [39]. In the current study, mice with milk-induced eosinophilia and leukocytosis were used to test the anti-asthmatic activity of LPE and LME at doses of 200 and 400 mg/kg. According to reports, giving milk subcutaneously causes a noticeable rise in the number of leukocytes and eosinophils 24 h later. Inflammatory mediators such as cytokines, histamine, and major basic proteins are released by leucocytes during asthmatic inflammation, promoting the continued inflammation. A peripheral eosinophil count that has abnormally increased to over 4% of the total leukocyte count is referred to as eosinophilia. The eosinophil count rises in asthmatic patients [40, 41].

While mice treated with various doses of plant extracts show a decrease in the difference in leukocyte and eosinophil counts, mice treated with 1% Tween-80 in the control group exhibit an increase in these two cell types. Quisqualis indica leaf extracts may be helpful in allergy conditions because adaptogenic and type I hypersensitivity mediate the decrease in leucocytes and eosinophils.

Mast cells degranulate in response to immunological stimuli where antigen antibody responses are prevalent. In a dose-dependent way, Quisqualis indica leaf extracts at doses of 200 and 400 mg/kg effectively prevent egg albumin-induced mast cell degranulation. At 400 mg/kg, LPE and LME protect mast cells similarly to disodium chromoglycate. This demonstrates the effectiveness of Quisqualis indica leaf extracts in type I hypersensitivity reactions and in mast cell stabilization. The anaphylactic allergic reaction, which can be triggered by a variety of triggers, is a potentially fatal reaction that releases mediators like histamine and pro-inflammatory cytokines.

The methanolic extract was subjected to a phytochemical analysis using the HRLCMS/MS technique, which revealed the presence of a number of phytocompounds including apigenin 7-glucoside, 3-Oxo-12, 18-ursadien-28-oic acid, 1-O-Caffeoyl-(b-D-glucose 6-O-sulfate), gallic acid, kurigalin, punicacortein B, etc. Gallic acid has shown a good amount of abundance in LME extract and acts by inhibiting mast cell activation, preventing the release of histamine, and the production of pro-inflammatory cytokines [42]. The highly galloylated compounds inhibits secretion of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in a concentration-dependent manner, acting on the transcriptional activity of NF-κB [43]. According to the pharmacological effects of flavonoids like kaempferol, quercetin, and rutin, they may be able to treat allergic inflammatory disorders by inhibiting mast cell activation [44]. Apigenin has been found to be effective in allergic asthma through the decreased activation of epithelial cells, T cells, and eosinophils [45]. As per HRLCMS data of LME extract the flavonoids like kaempferol, quercetin, apigenin, and luteolin and few types of tannin like gallic acid and punicacortein B are present in a notable amount. As a result, Quisqualis indica's leaf methanolic extract has shown significant mast cell degranulation and Milk-induced eosinophilia and leukocytosis action. Hence, Quisqualis indica leaves may be helpful in allergic conditions like asthma.

Conclusion

The plant extract is found to comprise phytochemicals such as apigenin 7-glucoside, 3-Oxo-12, 18-ursadien-28-oic acid, 1-O-Caffeoyl-(b-D-glucose 6-O-sulfate), gallic acid, kurigalin, punicacortein B, apigenin, kaempferol, quercetin, rutin, nicotinic acid methylbetaine (trigonelline), L-proline, L-asparagine, potassium quisqualate, etc. Thus, this plant is a plentiful source of phytochemicals with therapeutic value, and the findings of this study offer some scientific support for the use of the plant in traditional medicine for anthelmintic, anti-emetic, analgesic, antiulcer, and anti-diarrheal purposes. The results of the current investigation showed that milk-induced leucocytosis and eosinophilia reduced significantly by Quisqualis indica leaf extracts at 400 mg/kg dose. In anaphylactic reactions, extracts suppress the release of histamine and stabilize antigen-induced mast cells. They also have anti-allergic properties. As a result of its anti-allergic and mast cell-stabilizing properties, which might be due to the presence of flavonoids, tannins, and triterpenoids, Quisqualis indica leaf extracts are beneficial in treating asthma.

Availability of data and materials

The data that support the findings of this study are available from the corresponding author, upon reasonable request.

Abbreviations

LPE :

Leaf petroleum ether extract

LME:

Leaf methanolic extract

OECD:

The Organization for Economic Cooperation and Development

HRLMS/MS:

High Resolution Liquid Chromatography Mass Spectroscopy /Mass Spectroscopy

AJS :

Jet Stream Technology Ion Source

ESI :

Electrospray ionization

TOF/Q-TOF :

Tandem time-of-flight /quadrupole Tandem time-of-flight

RPMI-1640 :

Roswell Park Memorrial Institute

ANOVA :

Analysis of Variance

References

  1. Education NA, Program and P & 3 EPR (n.d.) (2007) Guidelines for the diagnosis and management of asthma. US department of health and human services, national institute of health

  2. Dharmage SC, Perret JL, Custovic A (2019) Epidemiology of asthma in children and adults. Front Pediatr 7(JUN):1–15. https://doi.org/10.3389/fped.2019.00246

    Article  Google Scholar 

  3. Guimarães CC, Sandy CM, Figueira R, da Rocha Gonçalves M, Crevelin EJ, Cardoso PH, Pereira AMS (2023) Anti-asthmatic activity of standardized hydro-ethanolic and aqueous extracts of Stachytarpheta cayennensis (Rich.) Vahl in a murine model. J Ethnopharmacol 302:115877. https://doi.org/10.1016/j.jep.2022.115877

    Article  CAS  PubMed  Google Scholar 

  4. Li Q, Abdulla R, Xin X, Xue G, Kang X, Zhao F, Asia HA (2023) Profiling of chemical constituents of Matricarla chamomilla L. by UHPLC-Q-Orbitrap-HRMS and in vivo evaluation its anti-asthmatic activity. Heliyon. https://doi.org/10.1016/j.heliyon.2023.e15470

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lim TK (2012) Edible medicinal and non-medicinal plants: volume 2, fruits. In: edible medicinal and non-medicinal plants. Vol 2, Fruits (Vol. 7). https://doi.org/10.1007/978-94-007-1764-0

  6. The Wealth of India (2005) A dictionary of indian raw materials and industrial products (Vol. VIII,). Council of scientific and industrial research

  7. Fang S, Chu JHF, Sheng CJH (1964) The chemical constituents of leaves of Shih-Chun-Tze, Quisqualis Indica L. Acta Chim Sinica 30:226–229

    CAS  Google Scholar 

  8. Bairagi VA, Shinde PR, Senthikumar KL, Sandu N (2012) Isolation and characterizations of phytoconstituents from Quisqualis indica Linn. (Combretaceae). Res J Pharm Phytochem 4:229–233. https://doi.org/10.5958/0975-4385

    Article  Google Scholar 

  9. Khare CP (2007) Indian medicinal plants: an illustrated dictionary. Springer Science Business Media, Cham. https://doi.org/10.1007/978-0-387-70638-2_1314

    Book  Google Scholar 

  10. Gurib-Fakim A (2012) Combretum indicum (L.) DeFilipps In: Schmelzer GH & Gurib-Fakim A (eds) Prota 11(2): Medicinal plants/Plants médicinales 2. PROTA, Wageningen, Netherlands Accessed 11 Apr 2019

  11. Shah A, Khan Z, Saleem S (2017) Antimicrobial potential of the crude extracts of an ethno botanically important plant Quisqualis indica Linn. Int J Biosci 10:335–344. https://doi.org/10.12692/ijb/10.1.335-344

    Article  CAS  Google Scholar 

  12. Ardana IB, Anthara MS, Dharmayudha AA, Subawa AA, Putra DH (2017) Wudani leaf extract (Quisqualis indica Linn) as traditional medicine to control the incidence of cattle worm. Bali Med J 6(1):17–22

    Article  Google Scholar 

  13. Singh N, Khatri P, Somantha KC, Damor R (2010) Antipyretic activity of methanolic extract of leaves of Quisqualis indica Linn. IJPRD 2:122–126

    Google Scholar 

  14. Yadav Y, Mohanty PK, Kasture SB (2011) Anti-inflammatory activity of hydro-alcoholic extract of Quisqualis indica Linn. flower in rats. Int J Pharm Life Sci 2:977–981

    Google Scholar 

  15. Sutar SB, Kadam SS, Patil SB, Patil SS, Mahajan RK (2020) Phytochemical investigation, anthelmintic and antioxidant activities of Quisqualis indica. Pharma Reson 3:15–21

    CAS  Google Scholar 

  16. Feng X, Jiang H, Zhang Y, He W, Zhang L (2012) Insecticidal activities of ethanol extracts from thirty Chinese medicinal plants against Spodoptera exigua (Lepidoptera: Noctuidae). J Med Plants Res 6:1263–1267. https://doi.org/10.5897/JMPR11.1324

    Article  Google Scholar 

  17. Yadav Y, Mohanty PK, Kasture SB (2011) Evaluation of immunomodulatory activity of hydro-alcoholic extract of Quisqualis indica Linn. flower in Wistar rats. Int J Pharm Life Sci 2:687–694

    Google Scholar 

  18. Singh N, Mohan G, Sharma RK, Ghaneshwari D (2013) Evaluation of anti-diarrhoeal activity of Quisqualis indica L. leaves. Indian J Nat Product Resour 4:155–160

    Google Scholar 

  19. Abd El-Rahman AAA, Abd El-Aleem IM, Refahy LA, El-Shazly MA (2016) Total phenolic content cytotoxic and antioxidant activities of Quisqualis indica (Linn.) growing in Egypt. Der Pharma Chemica 8:53–59

    CAS  Google Scholar 

  20. Nakarani KM (2002) Indian materia medica. Bombay Popular Prakashan (Vol. 1)

  21. Kirtikar K R, Basu B D (1993) Indian medicinal plants. Periodical Experts Book Agency, Vol. 2

  22. Khandelwal KR (2008) Practical pharmacognosy techniques and experiments. (19th ed.), Nirali Prakashan

  23. Nemade CT, Aher AN (2022) Pharmacognostic study and establishment of quality parameters of Quisqualis indica Linn. leaves. ECS Trans 107(1):14363

    Article  ADS  Google Scholar 

  24. Pariyani R, Ismail IS, Azam AA, Abas F, Shaari, k., Sulaiman, M.R., (2015) Phytochemical screening and acute oral toxicity study of java tea leaf extracts. BioMed Res Int. https://doi.org/10.1155/2015/742420

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mukherjee PK (2019) Quality control and evaluation of herbal drugs: Evaluating natural products and traditional medicine. In: Quality control and evaluation of herbal drugs: evaluating natural products and traditional medicine. https://doi.org/10.1016/C2016-0-04232-8

  26. OECD (2002) Test No. 423: acute oral toxicity—acute toxic class method, OECD guidelines for the testing of chemicals section 4. OECD Publishing, Paris, https://doi.org/10.1787/9789264071001-en

  27. Walum E (1998) Acute oral toxicity. Environ Health Perspect 106(Suppl 2):497–503. https://doi.org/10.1289/ehp.98106497

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Taur DJ, Patil RY (2011) Some medicinal plants with antiasthmatic potential: a current status. Asian Pac J Trop Biomed 1:413–418. https://doi.org/10.1016/S2221-1691(11)60091-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Nishigaki T (1988) Mast cell degranulation and its inhibition by an anti-allergic agent tranilast an electron microscopic study. Virchows Archiv B Cell Pathol Including Mol Pathol 55(5):311–322. https://doi.org/10.1007/BF02896590

    Article  CAS  Google Scholar 

  30. Bhujbal SS, Kumar D, Deoda RS, Deore TK, Patil MJ (2009) Antiasthmatic activity of roots of Hemidesmus indicus R. Br Pharmacologyonline 1:209–216

    Google Scholar 

  31. Andhare RN, Raut MK, Naik SR (2012) Evaluation of antiallergic and anti-anaphylactic activity of ethanolic extract of Sanseveiriatri fasciata leaves (EEST) in rodents. J Ethnopharmacol 142:627–633. https://doi.org/10.1016/j.jep.2012.05.007

    Article  CAS  PubMed  Google Scholar 

  32. Neupane P, Lamichhane J (2020) Phytochemical profiling using HRLCMS and evaluation of antioxidant and antibacterial activities of Nepalese medicinal plants. Int J Plant Res. https://doi.org/10.1007/s42535-020-00143-4

    Article  Google Scholar 

  33. Krystel-Whittemore M, Dileepan KN, Wood JG (2016) Mast cell: a multi-functional master cell. Front Immunol 6:620. https://doi.org/10.3389/fimmu.2015.00620

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Orr T, Cox J (1969) Disodium cromoglycate, an inhibitor of mast cell degranulation and histamine release induced by phospholipase A. Nature 223:197–198. https://doi.org/10.1038/223197b0

    Article  ADS  CAS  PubMed  Google Scholar 

  35. Howell JB, Altounyan RE (1967) A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 2(4166895):539–542. https://doi.org/10.1016/S0140-6736(67)90499-0

    Article  CAS  PubMed  Google Scholar 

  36. Solomon Y, Malkamu B, Berhan A, Eyayu T, Almaw A, Legese B, Woldu B (2023) Peripheral blood eosinophilia in adult asthmatic patients and its association with the severity of asthma. BMC Pulm Med 23:96. https://doi.org/10.1186/s12890-023-02383

    Article  PubMed  PubMed Central  Google Scholar 

  37. Nakagome K, Nagata M (2018) Involvement and possible role of eosinophils in asthma exacerbation. Front Immunol 9:2220. https://doi.org/10.3389/fimmu.2018.02220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Debierre-Grockiego F, Leduc I, Prin L, Gouilleux-Gruart V (2001) Dexamethasone inhibits apoptosis of eosinophils isolated from hypereosinophilic patients. Immunobiology 204(4):517–523. https://doi.org/10.1078/0171-2985-00060

    Article  CAS  PubMed  Google Scholar 

  39. Parmar G, Pundarikakshudu K, Balaraman R (2019) Anti-anaphylactic and anti-asthmatic activity of Euphorbia thymifolia L. on experimental animals. J Tradit Complement Med 9:60–65. https://doi.org/10.1016/j.jtcme.2018.03.002

    Article  PubMed  Google Scholar 

  40. Maji AK, Bhadra S, Mahapatra S, Banerji P, Banerjee D (2011) Mast cell stabilization and membrane protection activity of Barleria prionitis L. Pharmacogn J 3:67–71. https://doi.org/10.5530/pj.2011.24.13

    Article  Google Scholar 

  41. Parmar G, Pundarikakshudu K, Balaraman R, Sailor G (2018) Amelioration of anaphylaxis, mast cell degranulation and bronchospasm by Euphorbia hirta L. extracts in experimental animals. Beni-Suef Univ J Basic Appl Sci 7:127–134. https://doi.org/10.1016/j.bjbas.2017.11.001

    Article  Google Scholar 

  42. Choi CH, Kim SH (2006) Role of Gallic acid in inflammatory allergic process. In Korean J Physiol Pharmacol 10:101–108

    CAS  Google Scholar 

  43. Piazza S, Fumagalli M, Martinelli G, Pozzoli C, Maranta N, Angarano M, Dell’Agli M (2022) Hydrolyzable tannins in the management of Th1, Th2 and Th17 inflammatory-related diseases. Molecules 27(21):7593. https://doi.org/10.3390/molecules27217593

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Park HH, Lee S, Son HY, Park SB, Kim MS, Choi EJ, Singh TS, Ha JH, Lee MG, Kim JE, Hyun MC, Kwon TK, Kim YH, Kim SH (2008) Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharmacal Res 31:1303–1311. https://doi.org/10.1007/s12272-001-2110-5

    Article  CAS  Google Scholar 

  45. Kim SH, Quoc QL, Park HS, Shin YS (2023) The effect of apigenin, an aryl hydrocarbon receptor antagonist, in phthalate-exacerbated eosinophilic asthma model. J Cell Mol Med. https://doi.org/10.1111/jcmm.17804

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the management and Principal of Maratha Vidya Prasark’s College of Pharmacy, Nashik, and SNJB’s SSDJ College of Pharmacy for offering the facilities that are required and also to IIT Pawai for providing the facility of HRLCMS/MS of plant extract. Authors are thankful to the C.V. Jadhav, Botanical Survey of India, Pune for the plant authentication.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. SNJB’s SSDJ College of Pharmacy, Neminagar, Chandwad, Nashik, Maharashtra, 423101, India

    Charulata T. Nemade

  2. MVP’s College of Pharmacy, Nashik, Maharashtra, 422002, India

    Anilkumar N. Aher

Authors
  1. Charulata T. Nemade
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anilkumar N. Aher
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CTN carried out the sample collection, conceptualisation, extraction and anti-asthma activity, HRLCMS/MS analysis, results interpretation and write-up. The other author read and approved the final manuscript.

Corresponding author

Correspondence to Charulata T. Nemade.

Ethics declarations

Ethics approval and consent to participate

All the experimental procedures and protocols used in this study were reviewed and approved by the Institutional Animal Ethical Committee (IAEC) of MVP’s College of Pharmacy, Nashik, Maharashtra, India (Registration No. 121/1999/CPCSEA) constituted under Committee for Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment and Forests, Government of India (Annexure 1). The animal ethical committee of the institute has approved all the protocols of the study (Registration No. IAEC/Jan 2020/09).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nemade, C.T., Aher, A.N. Quisqualis indica Linn.: HRLCMS/MS profiling and anti-asthma activity of leaf extracts. Futur J Pharm Sci 10, 13 (2024). https://doi.org/10.1186/s43094-024-00586-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43094-024-00586-5

Keywords